Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Annals of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Journal of Hepatology|May 24, 2023
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Germline Variants Influence Chronic Liver Disease Progression through Distinct PathwaysMarijana Vujkovic, David E Kaplan, Jonas Ghouse, et al.
Journal of Hepatology|September 4, 2020
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysisKevin Teo, Kushala W M Abeysekera, Leon Adams, et al.
Nature Genetics|June 2, 2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validationMarijana Vujkovic, Shweta Ramdas, Kim M Lorenz, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Annals of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Journal of Hepatology|May 24, 2023
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Germline Variants Influence Chronic Liver Disease Progression through Distinct PathwaysMarijana Vujkovic, David E Kaplan, Jonas Ghouse, et al.
Journal of Hepatology|September 4, 2020
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysisKevin Teo, Kushala W M Abeysekera, Leon Adams, et al.
Nature Genetics|June 2, 2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validationMarijana Vujkovic, Shweta Ramdas, Kim M Lorenz, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 23